161 related articles for article (PubMed ID: 25171703)
1. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.
Cherian S; McCullouch V; Miller V; Dougherty K; Fromm JR; Wood BL
Cytometry B Clin Cytom; 2016 Jul; 90(4):387-92. PubMed ID: 26525770
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
Morgado JM; Sánchez-Muñoz L; Teodósio CG; Jara-Acevedo M; Alvarez-Twose I; Matito A; Fernández-Nuñez E; García-Montero A; Orfao A; Escribano L
Mod Pathol; 2012 Apr; 25(4):516-21. PubMed ID: 22222639
[TBL] [Abstract][Full Text] [Related]
4. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
5. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.
van Daele PL; Beukenkamp BS; Geertsma-Kleinekoort WM; Valk PJ; van Laar JA; van Hagen PM; van der Velden VH
Neth J Med; 2009 Apr; 67(4):142-6. PubMed ID: 19581658
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
[TBL] [Abstract][Full Text] [Related]
10. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
Perbellini O; Zamò A; Colarossi S; Zampieri F; Zoppi F; Bonadonna P; Schena D; Artuso A; Martinelli G; Chilosi M; Pizzolo G; Zanotti R
Cytometry B Clin Cytom; 2011 Nov; 80(6):362-8. PubMed ID: 21656905
[TBL] [Abstract][Full Text] [Related]
11. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).
Escribano L; Diaz-Agustin B; López A; Núñez López R; García-Montero A; Almeida J; Prados A; Angulo M; Herrero S; Orfao A;
Cytometry B Clin Cytom; 2004 Mar; 58(1):1-8. PubMed ID: 14994369
[TBL] [Abstract][Full Text] [Related]
13. Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis.
Nwogbo OV; Fang H; Wang W; Xu J; Miranda RN; Bose P; Ok CY; Jorgensen JL; Medeiros LJ; Wang SA
Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38372648
[TBL] [Abstract][Full Text] [Related]
14. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
15. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.
Akin C; Valent P; Escribano L
Curr Allergy Asthma Rep; 2006 Jul; 6(4):282-8. PubMed ID: 16822380
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
Núñez-López R; Escribano L; Schernthaner GH; Prados A; Rodríguez-González R; Díaz-Agustín B; López A; Hauswirth A; Valent P; Almeida J; Bravo P; Orfao A
Br J Haematol; 2003 Jan; 120(2):257-65. PubMed ID: 12542483
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
Escribano L; Díaz Agustín Beatriz ; Bravo P; Navalón R; Almeida J; Orfao A
Leuk Lymphoma; 1999 Oct; 35(3-4):227-35. PubMed ID: 10706445
[TBL] [Abstract][Full Text] [Related]
19. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]